[ARS] Genelux Corporation SEC Filing

Filing Impact

(No impact)

Filing Sentiment

(Neutral)

Form Type

ARS

Rhea-AI Filing Summary

07/11/2025 - 08:10 AM

ARS - Genelux Corporation

ARS Filing - Genelux Corporation

This filing is available as a PDF document.

Filing Type: ARS

Company: Genelux Corporation (GNLX)

Acceptance Date: 2025-07-11T08:10:38.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Genelux Corp

NASDAQ:GNLX

GNLX Rankings

#6186 Ranked by Market Cap

N/A Ranked by Dividends

GNLX Latest News

Jul 7, 2025

Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development

May 6, 2025

Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates

May 1, 2025

Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference

Mar 28, 2025

Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 25, 2025

Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock

GNLX Latest SEC Filings

Jul 11, 2025

[DEFA14A] Genelux Corporation Additional Proxy Soliciting Materials

Jul 11, 2025

[DEF 14A] Genelux Corporation Definitive Proxy Statement

Jul 2, 2025

[Form 4] Genelux Corporation Insider Trading Activity

Jul 2, 2025

[Form 3] Genelux Corporation Initial Statement of Beneficial Ownership

Jun 24, 2025

[Form 4] Genelux Corporation Insider Trading Activity

GNLX Stock Data

Market Cap 109.43M

Float 33.43M

Insiders Ownership 16.58%

Institutions Ownership 14.12%

Short Percent 7.09%

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City WESTLAKE VILLAGE